Pharmacokinetics of a novel closantel/ivermectin injection in cattle

被引:23
作者
Cromie, L [1 ]
Ferry, M [1 ]
Couper, A [1 ]
Fields, C [1 ]
Taylor, SM [1 ]
机构
[1] Norbrook Labs Ltd, Div Res, Newry BT35 6PU, Co Down, North Ireland
关键词
D O I
10.1111/j.1365-2885.2006.00738.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Two studies are described on the pharmacokinetics of a combination anthelmintic consisting of ivermectin and closantel for use in cattle. In the first, the pharmacokinetics of both active drugs in the combination were compared with the formulation with either ivermectin or closantel removed. No differences in the pharmacokinetics were observed, indicating that neither the absorption nor distribution of ivermectin or closantel in the combination were influenced by the presence of the other. In the second study the pharmacokinetics of ivermectin and closantel in the combination product were compared with control formulations of each. No difference was found between the closantel formulations. With ivermectin it was noted that absorption and excretion were more rapid and C-max higher in the combination, although the AUC of both formulations were not significantly different.
引用
收藏
页码:205 / 211
页数:7
相关论文
共 22 条
[1]   THE ABSORPTION, DISTRIBUTION AND ELIMINATION OF ANTHELMINTIC DRUGS - THE ROLE OF PHARMACOKINETICS [J].
BAGGOT, JD ;
MCKELLAR, QA .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1994, 17 (06) :409-419
[2]   WORM CONTROL AND ANTHELMINTIC RESISTANCE - ADVENTURES WITH A MODEL [J].
BARNES, EH ;
DOBSON, RJ ;
BARGER, IA .
PARASITOLOGY TODAY, 1995, 11 (02) :56-63
[3]   Macrocyclic lactones: distribution in plasma lipoproteins of several animal species including humans [J].
Bassissi, MF ;
Alvinerie, M ;
Lespine, A .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY, 2004, 138 (04) :437-444
[4]  
BOGAN JA, 1988, J VET PHARMACOL THER, V11, P260, DOI 10.1111/j.1365-2885.1988.tb00151.x
[5]   The effects of body composition on the pharmacokinetics of subcutaneously injected ivermectin and moxidectin in pigs [J].
Craven, J ;
Bjorn, H ;
Hennessy, DR ;
Friis, C .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2002, 25 (03) :227-232
[6]   DETERMINATION OF IVERMECTIN RESIDUES IN MEAT AND LIVER BY HPLC AND FLUOROMETRIC DETECTION [J].
DEGROODT, JM ;
DEBUKANSKI, BW ;
SREBRNIK, S .
JOURNAL OF LIQUID CHROMATOGRAPHY, 1994, 17 (06) :1419-1426
[7]   Fasciolicides: Efficacy, actions, resistance and its management [J].
Fairweather, I ;
Boray, JC .
VETERINARY JOURNAL, 1999, 158 (02) :81-112
[8]  
Hennessy D. R., 2002, P97, DOI 10.1079/9780851996172.0097
[9]   Comparative plasma disposition kinetics of ivermectin, moxidectin and doramectin in cattle [J].
Lanusse, C ;
Lifschitz, A ;
Virkel, G ;
Alvarez, L ;
Sanchez, S ;
Sutra, JF ;
Galtier, P ;
Alvinerie, M .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1997, 20 (02) :91-99
[10]   RELATIONSHIP BETWEEN PHARMACOLOGICAL PROPERTIES AND CLINICAL EFFICACY OF RUMINANT ANTHELMINTICS [J].
LANUSSE, CE ;
PRICHARD, RK .
VETERINARY PARASITOLOGY, 1993, 49 (2-4) :123-158